Brolucizumab in Pretreated Neovascular Age-Related Macular Degeneration: Case Series, Systematic Review, and Meta-Analysis

Brolucizumab in Pretreated Neovascular Age-Related Macular Degeneration: Case Series, Systematic Review, and Meta-Analysis

Background: Recalcitrant neovascular age-related macular degeneration (rnAMD) despite intensive intravitreal anti-neovascular endothelial growth factor (VEGF) treatment, can be handled by switching to another anti-VEGF agent. This first systematic review and meta-analysis presents long-term data aft...

Full description

Bibliographic Details
Main Authors: Christof Hänsli, Christin Schild, Isabel Pfister, Justus G. Garweg
Format: Article
Language:English
Published: MDPI AG 2023-03-01
Series:Life
Subjects:
neovascular age-related macular degeneration
brolucizumab
switch
meta-analysis
anti-VEGF
recalcitrant nAMD
Online Access:https://www.mdpi.com/2075-1729/13/3/814

Internet

https://www.mdpi.com/2075-1729/13/3/814

Similar Items